MX9205457A - Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion - Google Patents

Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion

Info

Publication number
MX9205457A
MX9205457A MX9205457A MX9205457A MX9205457A MX 9205457 A MX9205457 A MX 9205457A MX 9205457 A MX9205457 A MX 9205457A MX 9205457 A MX9205457 A MX 9205457A MX 9205457 A MX9205457 A MX 9205457A
Authority
MX
Mexico
Prior art keywords
mupirocina
procedure
preparation
new compounds
compounds derived
Prior art date
Application number
MX9205457A
Other languages
English (en)
Inventor
Nigel John Perryman Broom
Peter John O'hanlon
John Stephen Elder
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919120491A external-priority patent/GB9120491D0/en
Priority claimed from GB929201507A external-priority patent/GB9201507D0/en
Priority claimed from GB929219053A external-priority patent/GB9219053D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9205457A publication Critical patent/MX9205457A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9205457A 1991-09-26 1992-09-25 Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion MX9205457A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919120491A GB9120491D0 (en) 1991-09-26 1991-09-26 Novel compounds
GB929201507A GB9201507D0 (en) 1992-01-24 1992-01-24 Novel compounds
GB929219053A GB9219053D0 (en) 1992-09-09 1992-09-09 Novel compounds

Publications (1)

Publication Number Publication Date
MX9205457A true MX9205457A (es) 1993-03-01

Family

ID=27265863

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205457A MX9205457A (es) 1991-09-26 1992-09-25 Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion

Country Status (6)

Country Link
EP (1) EP0605524A1 (es)
JP (1) JPH06510781A (es)
AU (1) AU2594092A (es)
MX (1) MX9205457A (es)
PT (1) PT100902A (es)
WO (1) WO1993006118A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320594D0 (en) * 1993-10-06 1993-11-24 Zeneca Ltd Heterocyclic compounds
US6534037B1 (en) 1998-01-21 2003-03-18 Neorx Corporation Non-steroidal compounds for steroid receptors and uses relating thereto
US6291514B1 (en) 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
US7649098B2 (en) 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200920355A (en) 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
WO2017038650A1 (ja) * 2015-08-28 2017-03-09 積水メディカル株式会社 ベンジル化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0090603A3 (en) * 1982-03-25 1984-05-16 Beecham Group Plc Antibacterial compounds

Also Published As

Publication number Publication date
EP0605524A1 (en) 1994-07-13
PT100902A (pt) 1993-11-30
JPH06510781A (ja) 1994-12-01
AU2594092A (en) 1993-04-27
WO1993006118A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
MX9202290A (es) Nuevos derivados de tiopiranopirrol y procedimiento para su preparacion.
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX174176B (es) Compuestos azo y procedimiento para su preparacion
MX9100031A (es) Compuestos de amino silicona y procedimiento para su preparacion
MX10621A (es) Compuestos de piperazinil heterociclicos y procedimiento para su preparacion.
MX23672A (es) Derivados de glicopeptidos y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX9200273A (es) Nuevos compuestos de sulfonilureas y procedimientopara su obtencion
MX9202281A (es) Derivados de benzofurano y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
MX9205455A (es) Procedimiento para la preparacion de diritromicina cristalina
MX9204940A (es) Compuesto antiparasitario y procedimiento para su preparacion.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX9100845A (es) Nuevas tienodiazepinas y procedimiento para su preparacion
MX9101516A (es) Derivados de 1,2,5,6-tetrahidropiridin 3-cetoxima y-3-aldoxina y procedimiento para su preparacion
MX9100357A (es) Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion
MX9100743A (es) Compuestos heterociclicos y procedimiento para su preparacion
MX9205457A (es) Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9205747A (es) Pirazolinas y procedimiento para su preparacion.
MX9100811A (es) Indolonaftiridinas y procedimiento para su preparacion
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX21871A (es) Procedimiento para la preparacion de oxadiazolil fenoxialquilisoxazoles y compuestos resultantes